Holen Sie sich die Stockscreener-App
13.11
2.74%
0.35
Immunic Inc Aktie (IMUX) Neueste Nachrichten
Long term debt to total assets ratio of Immunic, Inc. – HAM:10V - TradingView
Discontinued operations of Immunic, Inc. – HAM:10V - TradingView
Why Did IMUX Stock Surge 33% Pre-Market Today? - Stocktwits
Wedbush initiates Immunic stock with Outperform rating By Investing.com - Investing.com Australia
IMUX Initiates Coverage On Wedbush -- Rating Set to Outperform - GuruFocus
Wedbush initiates Immunic stock with Outperform rating - Investing.com
Renaissance Technologies LLC Invests $1.02 Million in Immunic, Inc. $IMUX - MarketBeat
Immunic (NASDAQ:IMUX) Upgraded to "Hold" at Wall Street Zen - MarketBeat
Immunic Inc. (IMUX) Pulls Back 3.14% to $16.06 as Key Support at $15.26 Comes into FocusCall Flow Alert - Vinanet
Immunic, Inc. (IMUX): OrbiMed entities disclose 5.3% and 2.8% equity holdings - Stock Titan
Nantahala Capital discloses 7.47% Immunic (IMUX) stake in Schedule 13G/A - Stock Titan
Immunic (IMUX): Commodore Capital discloses 9.9% stake capped by warrant limits - Stock Titan
Immunic Inc (NASDAQ: IMUX) Share Price, IMUX Stock News, IMUX Share Price & Updates - Kalkine
Can Immunic (IMUX) Climb 163.03% to Reach the Level Wall Street Analysts Expect? - Yahoo Finance
Immunic (IMUX) sees Soleus Capital group disclose 4.9% beneficial stake - Stock Titan
H.C. Wainwright Maintains Immunic(IMUX.US) With Buy Rating, Maintains Target Price $22 - Moomoo
What date does Immunic's (IMUX) report EarningsEarnings Calendar & Announcement - Zacks Investment Research
Analysts Offer Insights on Healthcare Companies: Immunic (IMUX), Legend Biotech (LEGN) and Sagimet Biosciences, Inc. Class A (SGMT) - The Globe and Mail
Wolfe Research Maintains Immunic(IMUX.US) With Buy Rating, Cuts Target Price to $25 - Moomoo
Is Immunic Inc (IMUX) Struggling After Recent Earnings? EPS Misses Estimates with GF Score: 32/100 - GuruFocus
LifeSci Capital Maintains Immunic(IMUX.US) With Buy Rating, Maintains Target Price $56 - Moomoo
Small cap wrap: 1911 Gold, Dune Oil, Nextech3D.ai, C3 Metals, Immunic… - Proactive financial news
Immunic Releases Q2 2026 Financial Results - AlphaStreet
Immunic, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 - marketscreener.com
Form 8K Immunic Inc For: 11 August By Investing.com - Investing.com Nigeria
Immunic (NASDAQ:IMUX) Issues Quarterly Earnings Results, Beats Estimates By $0.36 EPS - MarketBeat
Immunic Appoints Biopharma Finance Veteran Elena Ridloff to Board of Directors - Minichart
Immunic Q2 Results: EPS beats estimates, losses narrow YoY - scanx.trade
Immunic advances MS drug vidofludimus calcium t... - Pluang
Immunic posts investor presentation highlighting vidofludimus calcium Phase 3 MS program - Bitget
Immunic CEO on Q2 progress and Phase 3 MS trial milestones - Proactive financial news
Immunic advances MS drug trials, expects Phase 3 data by end 2026 and plans NDA filing in 2027 - Pluang
Immunic Inc (IMUX) Q2 Earnings Beat Highlights Growth Potential Despite Unprofitability - GuruFocus
Immunic appoints Elena Ridloff to board ahead of Phase 3 MS readout - Quiver Quantitative
Immunic (IMUX) Advances Clinical Stage, Market Eyes Growth Despi - GuruFocus
Immunic: Q2 Earnings Snapshot - AOL.com
Immunic, Inc. Reports Second Quarter 2026 Financial Results and Provides Corporate Update - PR Newswire
Immunic advances MS drug toward key Phase 3 data, expects results by year-end - Proactive financial news
Immunic files Form 3 for director Elena Ridloff, reporting no beneficial ownership - Bitget
Immunic (IMUX) director Elena Ridloff receives 50,740 stock options at $14.54 - Stock Titan
Immunic appoints Elena Ridloff to board of directors By Investing.com - Investing.com Nigeria
Immunic appoints Elena Ridloff to board of directors - Investing.com
Immunic Appoints Elena Ridloff to Board of Directors - PR Newswire
Millennium entities (IMUX) disclose 7.0% beneficial ownership in Immunic common stock - Stock Titan
Immunic Inc (IMUX) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
IMUX Q2'26 Earnings: EPS estimate is (1.16) USD - TradingView
Laurion Capital discloses 6.06% Immunic (IMUX) stake via shares and warrants - Stock Titan
Immunic Inc expected to post a loss of $1.19 a shareEarnings Preview - TradingView
OMERS ADMINISTRATION Corp Makes New Investment in Immunic, Inc. $IMUX - MarketBeat
Immunic (NASDAQ:IMUX) Upgraded to "Strong-Buy" at LADENBURG THALM/SH SH - MarketBeat
Immunic Inc (IMUX) Valuation: PE, PB & Fair Value Analysis - TradingKey
Immunic Inc (IMUX) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Immunic Inc (IMUX) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Immunic Inc (IMUX) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
IMUX|Immunic Inc|Price:13.390|Chg%:-0.890 - TradingKey
IMUX|Immunic Inc|Price:13.970| - TradingKey
Immunic Inc (IMUX) Cash Flow - TradingKey
0.86%
0.31%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):